Press Releases
Morphic Names Bruce Rogers as President of Morphic Therapeutic and Blaise Lippa as Chief Scientific Officer
May 12, 2022
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022
May 4, 2022
Morphic Therapeutic Expands Leadership with Key Appointments in Clinical and Corporate Development
April 6, 2022
Morphic to Participate in BMO Inflammation and Immunology Spotlight Series Panel
March 30, 2022
Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patients with Ulcerative Colitis
March 25, 2022
Morphic Announces Participation In Cowen 42nd Annual Healthcare Conference
March 4, 2022
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2021
February 24, 2022
Morphic Presents Positive MORF-057 Data in Oral Presentation at ECCO 2022
February 22, 2022
Morphic Therapeutic to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference
January 5, 2022